Autonomous driving paper index

The emerging role of B cells in immune-mediated demyelinating diseases: mechanisms and therapeutic implications

2026-07-08 · Frontiers in Immunology

autonomous driving

One-line summary

An autonomous driving research paper: The emerging role of B cells in immune-mediated demyelinating diseases: mechanisms and therapeutic implications.

Engineering notes

Key topics: autonomous driving. See the paper for implementation details and experimental results.

Chinese explanation / 中文解读

中文解读待补充:本站会优先为端到端自动驾驶、BEV感知、3D目标检测、轨迹预测、路径规划、LiDAR感知等高价值论文补充中文说明。

Original abstract

Immune-mediated demyelinating diseases of the central nervous system, including multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), are unified by inflammatory injury to myelin and axons but differ fundamentally in their immunopathological mechanisms. Adaptive immune cells, particularly B cells and T cells, are central drivers of disease, contributing through both antibody-dependent and antibody-independent mechanisms. In MS, B cells exacerbate pathology via antigen presentation, cytokine secretion, and organization of ectopic lymphoid structures, consistent with the efficacy of anti-CD20 therapies despite largely preserved circulating immunoglobulin levels. In NMOSD, B cells and plasma cell progeny play a direct pathogenic role through aquaporin-4–specific (AQP-4) antibodies, establishing a model of antibody-mediated astrocytopathy. MOGAD occupies an intermediate immunopathological niche, with pathogenic antibodies targeting myelin oligodendrocyte glycoprotein (MOG) coexisting with additional, incompletely defined immune mechanisms. Recent advances from single-cell profiling, high-resolution imaging, and experimental models suggest substantial heterogeneity in B-cell developmental states, tolerance checkpoints, and tissue residency, challenging uniform approaches to B-cell–directed therapy. This review synthesizes current understanding of B-cell biology across demyelinating diseases, highlighting mechanisms of pathogenicity, immune regulation, and tolerance failure, and discusses implications for precision immunomodulatory strategies.

5.0Engineering value
7.0Research novelty
5.0Business relevance

Links and sources

Need this topic turned into a technical roadmap?

Full Self Driving can prepare a custom autonomous driving literature review, code map, dataset map, and B2B technology assessment.

Request B2B research

Comments

No comments yet. Be the first to share your thoughts on this paper.
Login or register to leave a comment